Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 68,755
Sort by:

Asia-Pacific Specialty Gas Market

US$ 2,500.00

... the other high cost specialty gasses such as bromine. Key Market Players The Key Market Players for Asia-Pacific specialty gas market are listed below: The ... Linde Group Air Liquide Southern Industrial Gas Sdn ...

January 2019 100 pages

Europe Surgical Visualization Products Market

US$ 2,500.00

... of the internal organ in the hospitals. Key Market Players The Key Market Players for Europe surgical visualization products market are listed below: Karl Storz Gmbh & Co. Kg. Medtronic ...

January 2019 100 pages

Global Surgical Visualization Products Market

US$ 4,200.00

... of the internal organ in the hospitals. Key Market Players The Key Market Players for global surgical visualization products market are listed below: Karl Storz Gmbh & Co. Kg. Medtronic ...

January 2019 237 pages

Middle East and Africa Surgical Visualization Products Market

US$ 2,500.00

Middle East & Africa surgical visualization products market is expected to reach a CAGR of 8.9% in the forecast period of ... hospitals. Key Market Players The Key Market Players for Middle East & Africa surgical visualization products market are listed below: Karl Storz Gmbh ...

January 2019 100 pages

North America Surgical Visualization Products Market

US$ 2,500.00

North America surgical visualization products market is expected to reach a CAGR of 10.2% in the forecast period of 2019 to 2026. ... hospitals. Key Market Players The Key Market Players for North America surgical visualization products market are listed below: Karl Storz Gmbh & Co. Kg. Medtronic CONMED ...

January 2019 100 pages

Asia-Pacific Surgical Visualization Products Market

US$ 2,500.00

... of the internal organ in the hospitals. Key Market Players The Key Market Players for Asia-Pacific surgical visualization products market are listed below: Karl Storz Gmbh & Co. Kg. Medtronic ...

January 2019 100 pages

Europe Laryngoscopes Market

US$ 2,500.00

... Hence diagnostics segment is dominating the Europe laryngoscopes market. In end user, hospitals segment is dominating in the market. The hospital segment in the ... reason of the growth of the market. Key Market Players The Key Market Players for Europe laryngoscopes market are listed below: Teleflex Incorporated ...

January 2019 100 pages

Global Laryngoscopes Market

US$ 4,200.00

... Hence diagnostics segment is dominating the global laryngoscopes market. In end user, hospitals segment is dominating in the market. The hospital segment in the ... reason of the growth of the market. Key Market Players The Key Market Players for global laryngoscopes market are listed below: Teleflex Incorporated ...

January 2019 256 pages

Middle East and Africa Laryngoscopes Market

US$ 2,500.00

... it is used as surgical guided. Hence diagnostics segment is dominating the Middle East & Africa laryngoscopes market. In end user, hospitals segment is dominating in the market ... Market Players The Key Market Players for Middle East & Africa laryngoscopes market are listed below: Teleflex Incorporated Olympus ...

January 2019 100 pages

North America Laryngoscopes Market

US$ 2,500.00

... diagnostics segment is dominating the North America laryngoscopes market. In end user, hospitals segment is dominating in the market. The hospital segment in the ... of the growth of the market. Key Market Players The Key Market Players for North America laryngoscopes market are listed below: Teleflex Incorporated ...

January 2019 100 pages

Asia-Pacific Laryngoscopes Market

US$ 2,500.00

... diagnostics segment is dominating the Asia-Pacific laryngoscopes market. In end user, hospitals segment is dominating in the market. The hospital segment in the ... of the growth of the market. Key Market Players The Key Market Players for Asia-Pacific laryngoscopes market are listed below: Teleflex Incorporated ...

January 2019 100 pages

North America Biological Safety Market

US$ 1,800.00

... & research institutions, industrial and others. Key Market Players The Key Market Players for North America biological safety cabinet market are listed below: Thermo Fisher Scientific ...

January 2019 100 pages

U.S.Surgical Visualization Products Market

US$ 1,800.00

... of the internal organ in the hospitals. Key Market Players The Key Market Players for U.S. surgical visualization products market are listed below: Karl Storz Gmbh & Co. Kg. Medtronic ...

January 2019 100 pages

China Surgical Visualization Products Market

US$ 1,800.00

... of the internal organ in the hospitals. Key Market Players The Key Market Players for China surgical visualization products market are listed below: Karl Storz Gmbh & Co. Kg. Medtronic ...

January 2019 100 pages

Back-end Revenue Cycle Management Market by Product and Services (Claim Processing, Denial Management, Payment Integrity), Delivery Mode (On-Premise, Cloud Based), End-User (Payer, Provider (Inpatient, Outpatient)), and Region - Global Forecast to 2023

US$ 3,390.00

... period.” The global back-end revenue cycle management market is projected to reach USD 10.4 billion by 2023 from USD 8.1 billion in 2018, at a CAGR of 5.0%. Growth in the back-end revenue cycle management market can be attributed to factors ...

January 2019 137 pages

Global Amebiasis Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... are 15 Chapters to deeply display the global Amebiasis Therapeutics market. Chapter 1, to describe Amebiasis Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the ...

January 2019 120 pages

Global Amebiasis Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... are 15 Chapters to deeply display the global Amebiasis Treatment market. Chapter 1, to describe Amebiasis Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the ...

January 2019 116 pages

Global Amyotrophic Lateral Sclerosis Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... Other There are 15 Chapters to deeply display the global Amyotrophic Lateral Sclerosis Therapeutics market. Chapter 1, to describe Amyotrophic Lateral Sclerosis Therapeutics Introduction, product scope, market overview, market opportunities, market ...

January 2019 124 pages

Global Anaplastic Large Cell Lymphoma Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... Other There are 15 Chapters to deeply display the global Anaplastic Large Cell Lymphoma market. Chapter 1, to describe Anaplastic Large Cell Lymphoma Introduction, product scope, market overview, market opportunities, market ...

January 2019 122 pages

Global Anaplastic Thyroid Cancer Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... display the global Anaplastic Thyroid Cancer market. Chapter 1, to describe Anaplastic Thyroid Cancer Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Anaplastic Thyroid Cancer, with ...

January 2019 108 pages

Global Anaplastic Thyroid Cancer Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... Other There are 15 Chapters to deeply display the global Anaplastic Thyroid Cancer Therapeutics market. Chapter 1, to describe Anaplastic Thyroid Cancer Therapeutics Introduction, product scope, market overview, market opportunities, market ...

January 2019 105 pages

Global Anaplastic Thyroid Cancer Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... Other There are 15 Chapters to deeply display the global Anaplastic Thyroid Cancer Treatment market. Chapter 1, to describe Anaplastic Thyroid Cancer Treatment Introduction, product scope, market overview, market opportunities, market ...

January 2019 104 pages

Global Custom Gene Expression Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... display the global Custom Gene Expression market. Chapter 1, to describe Custom Gene Expression Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Custom Gene Expression, with ...

January 2019 124 pages

Global DNA Oligonucleotide Synthesis Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... display the global DNA Oligonucleotide Synthesis market. Chapter 1, to describe DNA Oligonucleotide Synthesis Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of DNA Oligonucleotide Synthesis, with ...

January 2019 122 pages

Global Gene Synthesis Service Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... display the global Gene Synthesis Service market. Chapter 1, to describe Gene Synthesis Service Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Gene Synthesis Service, with ...

January 2019 124 pages

Global Oligonucleotide Synthesis Services Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... display the global Oligonucleotide Synthesis Services market. Chapter 1, to describe Oligonucleotide Synthesis Services Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Oligonucleotide Synthesis Services, with ...

January 2019 123 pages

Global Probiotic-based Dietary Supplements Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

US$ 3,480.00

... ” bacteria. The organisms themselves are also called probiotics. Scope of the Report: The global Probiotic-based Dietary Supplements market is valued at xx million USD in 2018 and is expected to reach ...

January 2019 115 pages

Global Protein Expression Service Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... display the global Protein Expression Service market. Chapter 1, to describe Protein Expression Service Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Protein Expression Service, with ...

January 2019 116 pages

Global Protein Production Service Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... display the global Protein Production Service market. Chapter 1, to describe Protein Production Service Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Protein Production Service, with sales ...

January 2019 123 pages

Global Traveler’s Diarrhea Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... into Adult Traveler's Diarrhea Children Traveler's Diarrhea There are 15 Chapters to deeply display the global Traveler’s Diarrhea Treatment market. Chapter 1, to describe Traveler’s Diarrhea Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving ...

January 2019 120 pages

2019 Future of Acromegaly R&D Pipeline Drugs and Companies- Analysis of Global Acromegaly Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Acromegaly Report Description The H1 2019 pipeline review report on Acromegaly pipeline is a comprehensive study on the candidates in development ...

January 2019 65 pages

2019 Future of Actinic (Solar) Keratosis R&D Pipeline Drugs and Companies- Analysis of Global Actinic (Solar) Keratosis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... into Phase 3 or Phase 4. Actinic (Solar) Keratosis Report Description The H1 2019 pipeline review report on Actinic (Solar) Keratosis pipeline is a comprehensive ... detailed analysis on all active Actinic (Solar) Keratosis pipeline compounds. The Actinic (Solar) Keratosis pipeline guide presents information ...

January 2019 50 pages

2019 Future of Angina/Angina Pectoris R&D Pipeline Drugs and Companies- Analysis of Global Angina (Angina Pectoris) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... some of the Angina (Angina Pectoris) pipeline companies from advancing their products into Phase 3 or Phase 4. Angina (Angina Pectoris) Report Description The H1 2019 pipeline review report on Angina (Angina Pectoris) pipeline ...

January 2019 75 pages

2019 Future of Arrhythmias R&D Pipeline Drugs and Companies- Analysis of Global Arrhythmias Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Arrhythmias Report Description The H1 2019 pipeline review report on Arrhythmias pipeline is a comprehensive study on the candidates in development ...

January 2019 50 pages

2019 Future of Arterial Thrombosis R&D Pipeline Drugs and Companies- Analysis of Global Arterial Thrombosis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... into Phase 3 or Phase 4. Arterial Thrombosis Report Description The H1 2019 pipeline review report on Arterial Thrombosis pipeline is a comprehensive study on ... and actionable insights. Scope of Arterial Thrombosis pipeline report includes An overview of Arterial Thrombosis disease including symptoms, causes, ...

January 2019 60 pages

2019 Future of Atrial Fibrillation R&D Pipeline Drugs and Companies- Analysis of Global Atrial Fibrillation Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... into Phase 3 or Phase 4. Atrial Fibrillation Report Description The H1 2019 pipeline review report on Atrial Fibrillation pipeline is a comprehensive study on ... and actionable insights. Scope of Atrial Fibrillation pipeline report includes An overview of Atrial Fibrillation disease including symptoms, causes, ...

January 2019 85 pages

2019 Future of Axillary Hyperhidrosis R&D Pipeline Drugs and Companies- Analysis of Global Axillary Hyperhidrosis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... into Phase 3 or Phase 4. Axillary Hyperhidrosis Report Description The H1 2019 pipeline review report on Axillary Hyperhidrosis pipeline is a comprehensive study ... insights. Scope of Axillary Hyperhidrosis pipeline report includes An overview of Axillary Hyperhidrosis disease including symptoms, causes ...

January 2019 45 pages

2019 Future of Behcet Disease R&D Pipeline Drugs and Companies- Analysis of Global Behcet Disease Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... products into Phase 3 or Phase 4. Behcet Disease Report Description The H1 2019 pipeline review report on Behcet Disease pipeline is a comprehensive study on ... and actionable insights. Scope of Behcet Disease pipeline report includes An overview of Behcet Disease disease including symptoms, causes, diagnosis ...

January 2019 60 pages

2019 Future of Bullous Pemphigoid R&D Pipeline Drugs and Companies- Analysis of Global Bullous Pemphigoid Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... into Phase 3 or Phase 4. Bullous Pemphigoid Report Description The H1 2019 pipeline review report on Bullous Pemphigoid pipeline is a comprehensive study on ... and actionable insights. Scope of Bullous Pemphigoid pipeline report includes An overview of Bullous Pemphigoid disease including symptoms, causes, ...

January 2019 60 pages

2019 Future of Burns R&D Pipeline Drugs and Companies- Analysis of Global Burns Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... of the Burns pipeline companies from advancing their products into Phase 3 or Phase 4. Burns Report Description The H1 2019 pipeline review ... report on Burns pipeline is a comprehensive study on the candidates ...

January 2019 75 pages

2019 Future of Chronic Urticaria/Hives R&D Pipeline Drugs and Companies- Analysis of Global Chronic Urticaria Or Hives Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... of the Chronic Urticaria Or Hives pipeline companies from advancing their products into Phase 3 or Phase 4. Chronic Urticaria Or Hives Report Description The H1 2019 pipeline review report on Chronic Urticaria Or Hives pipeline is a comprehensive ...

January 2019 65 pages

2019 Future of Contact Dermatitis R&D Pipeline Drugs and Companies- Analysis of Global Contact Dermatitis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... into Phase 3 or Phase 4. Contact Dermatitis Report Description The H1 2019 pipeline review report on Contact Dermatitis pipeline is a comprehensive study on ... and actionable insights. Scope of Contact Dermatitis pipeline report includes An overview of Contact Dermatitis disease including symptoms, causes, ...

January 2019 40 pages

2019 Future of Coronary Artery Disease (CAD)/Ischemic Heart Disease R&D Pipeline Drugs and Companies- Analysis of Global Coronary Artery Disease (CAD) (Ischemic Heart Disease) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... 3 or Phase 4. Coronary Artery Disease (CAD) (Ischemic Heart Disease) Report Description The H1 2019 pipeline review report on Coronary Artery Disease (CAD) ( ... originating companies, license providers and universities participating in the Coronary Artery Disease (CAD) (Ischemic Heart Disease) product pipeline ...

January 2019 120 pages

2019 Future of Critical Limb Ischemia R&D Pipeline Drugs and Companies- Analysis of Global Critical Limb Ischemia Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... into Phase 3 or Phase 4. Critical Limb Ischemia Report Description The H1 2019 pipeline review report on Critical Limb Ischemia pipeline is a comprehensive study ... presents detailed analysis on all active Critical Limb Ischemia pipeline compounds. The Critical Limb Ischemia pipeline guide presents information ...

January 2019 100 pages

2019 Future of Deep Vein Thrombosis (DVT) R&D Pipeline Drugs and Companies- Analysis of Global Deep Vein Thrombosis (DVT) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Deep Vein Thrombosis (DVT) Report Description The H1 2019 pipeline review report on Deep Vein Thrombosis (DVT) pipeline is a comprehensive study ...

January 2019 40 pages

2019 Future of Dilated Cardiomyopathy R&D Pipeline Drugs and Companies- Analysis of Global Dilated Cardiomyopathy Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... into Phase 3 or Phase 4. Dilated Cardiomyopathy Report Description The H1 2019 pipeline review report on Dilated Cardiomyopathy pipeline is a comprehensive study ... insights. Scope of Dilated Cardiomyopathy pipeline report includes An overview of Dilated Cardiomyopathy disease including symptoms, causes ...

January 2019 60 pages

2019 Future of Epidermolysis Bullosa R&D Pipeline Drugs and Companies- Analysis of Global Epidermolysis Bullosa Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... into Phase 3 or Phase 4. Epidermolysis Bullosa Report Description The H1 2019 pipeline review report on Epidermolysis Bullosa pipeline is a comprehensive study on ... actionable insights. Scope of Epidermolysis Bullosa pipeline report includes An overview of Epidermolysis Bullosa disease including symptoms, causes ...

January 2019 90 pages

2019 Future of Graves Diseases R&D Pipeline Drugs and Companies- Analysis of Global Graves Diseases Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... into Phase 3 or Phase 4. Graves Diseases Report Description The H1 2019 pipeline review report on Graves Diseases pipeline is a comprehensive study on ... and actionable insights. Scope of Graves Diseases pipeline report includes An overview of Graves Diseases disease including symptoms, causes, diagnosis ...

January 2019 40 pages

2019 Future of Hidradenitis Suppurativa R&D Pipeline Drugs and Companies- Analysis of Global Hidradenitis Suppurativa Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Hidradenitis Suppurativa Report Description The H1 2019 pipeline review report on Hidradenitis Suppurativa pipeline is a comprehensive study on the candidates in development ...

January 2019 85 pages

2019 Future of Hypertrophic Cardiomyopathy R&D Pipeline Drugs and Companies- Analysis of Global Hypertrophic Cardiomyopathy Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Hypertrophic Cardiomyopathy Report Description The H1 2019 pipeline review report on Hypertrophic Cardiomyopathy pipeline is a comprehensive study on the candidates in development ...

January 2019 60 pages

Filters

Search

Categories

186
1,016
32
226
188
159
141
128
63,618
1,124
756
1,021
160

Publishers

179
1
239
347
389
103
1,039
148
348
3
202
3
6
1,620
487
76
123
208
112
25
1,049
378
23
40
68
482
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,806
60
1,696
8
7,373
2,207
4,664
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
354
8
3
18
58
906
6
89
12
24
15
1,285
227
128
386
3
74
10
119
230
46
474
26
133
4

Regions

90
58
45
41
41
35
31
30
30
29
28
28
28
26
21
18
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
795
495
2
2
2
117
196
102
53
23
704
26
134
527
177
632
63,714

Price

Date

Pages

Offers

1
280
1
1